ATE348876T1 - Verfahren zur vermehrung von natürlichen killerzellen - Google Patents
Verfahren zur vermehrung von natürlichen killerzellenInfo
- Publication number
- ATE348876T1 ATE348876T1 AT00976285T AT00976285T ATE348876T1 AT E348876 T1 ATE348876 T1 AT E348876T1 AT 00976285 T AT00976285 T AT 00976285T AT 00976285 T AT00976285 T AT 00976285T AT E348876 T1 ATE348876 T1 AT E348876T1
- Authority
- AT
- Austria
- Prior art keywords
- natural killer
- killer cells
- human
- producing natural
- cells
- Prior art date
Links
- 210000000822 natural killer cell Anatomy 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract 2
- 208000008383 Wilms tumor Diseases 0.000 abstract 1
- 238000003501 co-culture Methods 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000008026 nephroblastoma Diseases 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001152—Transcription factors, e.g. SOX or c-MYC
- A61K39/001153—Wilms tumor 1 [WT1]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4613—Natural-killer cells [NK or NK-T]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33607999A JP3619853B2 (ja) | 1999-11-26 | 1999-11-26 | ナチュラルキラー細胞の増殖方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE348876T1 true ATE348876T1 (de) | 2007-01-15 |
Family
ID=18295489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00976285T ATE348876T1 (de) | 1999-11-26 | 2000-11-16 | Verfahren zur vermehrung von natürlichen killerzellen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1233058B1 (de) |
JP (1) | JP3619853B2 (de) |
KR (1) | KR20030032905A (de) |
CN (1) | CN1237170C (de) |
AT (1) | ATE348876T1 (de) |
CA (1) | CA2393322A1 (de) |
DE (1) | DE60032508D1 (de) |
HK (1) | HK1048498A1 (de) |
TW (1) | TWI224137B (de) |
WO (1) | WO2001038494A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1288291A4 (de) * | 2000-06-06 | 2004-05-12 | Kirin Brewery | Methode zur verfielfältigung von natürlichen killer-t-zellen |
JP2002045174A (ja) * | 2000-07-31 | 2002-02-12 | Inst Of Physical & Chemical Res | ナチュラルキラー細胞増殖法 |
CA2544155C (en) | 2004-09-15 | 2012-10-16 | Tetsuya Kuhara | Drug and method for proliferating natural killer cells |
CN1859917B (zh) | 2004-09-29 | 2011-08-03 | 森永乳业株式会社 | 用于改善高血糖的药物和食品或饮料 |
JP2008109866A (ja) * | 2006-10-30 | 2008-05-15 | Jms Co Ltd | 培地添加剤、この培地添加剤を含む培地、及びこの培地を用いた細胞の培養方法 |
MX2007015736A (es) * | 2007-12-11 | 2009-06-11 | Val De Bio S De R L De C V | Procedimiento para sensibilizar celulas y el uso de las mismas para tratamiento de tumores. |
SG11201505858VA (en) | 2013-01-28 | 2015-09-29 | St Jude Childrens Res Hospital | A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease |
KR102211120B1 (ko) | 2014-05-15 | 2021-02-03 | 내셔널 유니버시티 오브 싱가포르 | 변형된 천연 살해 세포 및 그의 용도 |
CN104611293B (zh) * | 2014-12-30 | 2017-10-13 | 杭州特马赛生物技术有限公司 | 一种体外中药组合诱导扩增nk细胞的方法及其应用 |
CN104789527B (zh) * | 2015-05-15 | 2018-05-29 | 江苏杰晟生物科技有限公司 | 一种自体自然杀伤细胞鸡尾酒式培养的制备方法及其试剂盒产品 |
CN107064085B (zh) * | 2017-03-16 | 2021-05-11 | 中国人民解放军三〇七医院 | 自然杀伤细胞活性测定方法 |
JP7256749B2 (ja) | 2017-03-27 | 2023-04-12 | ナショナル ユニヴァーシティー オブ シンガポール | ナチュラルキラー細胞免疫療法における切断されたnkg2dキメラ受容体及びその使用 |
MX2019011570A (es) | 2017-03-27 | 2019-11-18 | Nat Univ Singapore | Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales. |
AU2020232691B2 (en) | 2019-03-05 | 2023-06-29 | Nkarta, Inc. | CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
CN112251405A (zh) * | 2020-10-15 | 2021-01-22 | 大连天星生物技术有限责任公司 | 一种体外高效诱导扩增nk细胞的方法 |
CN112285083B (zh) * | 2020-10-28 | 2022-01-07 | 上海睿钰生物科技有限公司 | 一种细胞杀伤效力的评价方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5415874A (en) * | 1989-10-31 | 1995-05-16 | The Board Of Trustees Of The Leland Stanford Junior University | Natural killer cell lines and clones with antigen specificity |
ES2227688T3 (es) * | 1996-04-17 | 2005-04-01 | Albert, Winfried, Dr. | Procedimiento para la produccion y multiplicacion de linfocitos. |
FR2775692B1 (fr) * | 1998-03-03 | 2000-06-16 | Roussy Inst Gustave | Methodes d'activation de cellules tueuses naturelles (nk) et moyens de mise en oeuvre |
-
1999
- 1999-11-26 JP JP33607999A patent/JP3619853B2/ja not_active Expired - Fee Related
-
2000
- 2000-11-16 WO PCT/JP2000/008079 patent/WO2001038494A1/ja active IP Right Grant
- 2000-11-16 AT AT00976285T patent/ATE348876T1/de not_active IP Right Cessation
- 2000-11-16 CA CA002393322A patent/CA2393322A1/en not_active Abandoned
- 2000-11-16 DE DE60032508T patent/DE60032508D1/de not_active Expired - Lifetime
- 2000-11-16 CN CNB008163162A patent/CN1237170C/zh not_active Expired - Fee Related
- 2000-11-16 KR KR1020027006659A patent/KR20030032905A/ko not_active Application Discontinuation
- 2000-11-16 EP EP00976285A patent/EP1233058B1/de not_active Expired - Lifetime
- 2000-11-24 TW TW089125163A patent/TWI224137B/zh not_active IP Right Cessation
-
2003
- 2003-01-23 HK HK03100622.3A patent/HK1048498A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
DE60032508D1 (de) | 2007-02-01 |
EP1233058A4 (de) | 2003-01-15 |
CA2393322A1 (en) | 2001-05-31 |
CN1237170C (zh) | 2006-01-18 |
WO2001038494A1 (fr) | 2001-05-31 |
TWI224137B (en) | 2004-11-21 |
EP1233058B1 (de) | 2006-12-20 |
EP1233058A1 (de) | 2002-08-21 |
CN1399675A (zh) | 2003-02-26 |
JP3619853B2 (ja) | 2005-02-16 |
JP2001149069A (ja) | 2001-06-05 |
KR20030032905A (ko) | 2003-04-26 |
HK1048498A1 (zh) | 2003-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE348876T1 (de) | Verfahren zur vermehrung von natürlichen killerzellen | |
ATE358493T1 (de) | Menschliche mesenchymale stammzellen aus peripherem blut | |
ATE270323T1 (de) | Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo | |
UA81398C2 (en) | Keratinocytes which may be used as biologically active substances for the treatment of wounds | |
IL210618A0 (en) | Population of multipotent adult stem cells expressing telomerase and being cd45- and glycophorin a-, methods for their preparation and uses | |
WO2001036589A3 (en) | Human ex vivo immune system | |
WO2004055155A3 (en) | Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same | |
PT794790E (pt) | Libertacao localizada de factores que aumentam a sobrevivencia de celulas transplantadas | |
SG152273A1 (en) | Pdx1 expressing endoderm | |
DK1082410T3 (da) | Humane CD45 - og/eller fibroblast mesenchymale stamceller | |
WO2004011603A3 (en) | Functional cardiomyocytes from human embryonic stem cells | |
DE69329779D1 (de) | Verfahren zur behandlung geschädigter und verminderter zellen | |
DE69030765T2 (de) | Medien zur zellzucht und verfahren dazu | |
WO2002010350A1 (fr) | Technique de proliferation de cellules tueuses naturelles | |
GB9825096D0 (en) | Cells,culture methods and their uses | |
ATE314461T1 (de) | Vermehrte und genetisch modifizierte populationen menschlicher hämatopoitischer stammzellen | |
CY1107603T1 (el) | Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης | |
EP2377922A3 (de) | PDX1-exprimierendes Endoderm | |
DE60213852D1 (de) | Herstellung von zellsuspensionen | |
ES2048142T3 (es) | Procedimiento de obtencion de polidesoxirribonucleotidos sustancialmente puros y no informacionales que tienen actividades biologicas, y producto respectivo. | |
TW200510011A (en) | A method for regeneration of bone | |
NZ508602A (en) | The production of primmorphs from disassociated cells of sponges, corals and other invertebrates, and use thereof | |
MXPA03009312A (es) | Metodo para trasplante autologo. | |
DE60132466D1 (de) | Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen | |
DE69934399D1 (de) | Komplex aus peptid und mhc-peptid auf oberfläche von phagen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |